Suchergebnisse - "Drummond, Michael F"

PubPharm (181)

21

The Cost-Effectiveness of Expanding Vaccination with a Cell-Based Influenza Vaccine to Low Risk Adults Aged 50 to 64 Years in the United Kingdom

enthalten in: Vaccines | 2021

von Kohli, M. | Maschio, M. | Mould-Quevedo, J. | +3

22

A Value Framework for the Assessment of Diagnostic Technologies : A Proposal Based on a Targeted Systematic Review and a Multistakeholder Deliberative Process in Latin America

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2021

von Augustovski, F. | Alfie, V. | Alcaraz, A. | +3

23

The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19)

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2020

von Mullins, C. | Drummond, M.

CommentOn: Value Health. 2020 Nov;23(11):1432-1437. - PMID 33127013

24

Lifecycle evidence requirements for high-risk implantable medical devices : a European perspective

enthalten in: Expert review of medical devices | 2020

von Tarricone, R. | Ciani, O. | Torbica, A. | +9

25

Taking Steps Toward Transparency in Real-World Evidence Studies

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2020

von Drummond, M.

26

Yes, Authorship Is Important

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2020

von Drummond, M. | Mullins, C.

27

Modeling in Early Stages of Technology Development : Is an Iterative Approach Needed? Comment on "Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling"

enthalten in: International journal of health policy and management | 2020

von Drummond, M.

CommentOn: Int J Health Policy Manag. 2019 Aug 01;8(10):575-582. - PMID 31657184

28

Reproducible research practices, openness and transparency in health economic evaluations : study protocol for a cross-sectional comparative analysis

enthalten in: BMJ open | 2020

von Catalá-López, F. | Caulley, L. | Ridao, M. | +10

29

Do Social Values and Institutional Context Shape the Use of Economic Evaluation in Reimbursement Decisions? An Empirical Analysis

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2020

von Torbica, A. | Fornaro, G. | Tarricone, R. | +1

30

Analytic Considerations in Applying a General Economic Evaluation Reference Case to Gene Therapy

enthalten in: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | 2019

von Drummond, M. | Neumann, P. | Sullivan, S. | +4